SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,568,095 | +4.3% | 26,246 | -5.4% | 1.31% | +9.9% |
| Q2 2023 | $5,337,880 | -9.1% | 27,735 | -4.4% | 1.19% | -12.0% |
| Q1 2023 | $5,874,667 | +48.4% | 29,015 | -5.8% | 1.35% | +49.3% |
| Q4 2022 | $3,959,658 | -6.7% | 30,812 | -0.6% | 0.91% | -12.5% |
| Q3 2022 | $4,243,000 | -23.7% | 31,008 | -1.2% | 1.04% | +31.0% |
| Q2 2022 | $5,559,000 | +23.4% | 31,383 | +0.3% | 0.79% | +45.2% |
| Q1 2022 | $4,506,000 | +28.2% | 31,280 | +37.6% | 0.54% | +26.5% |
| Q4 2021 | $3,514,000 | -9.2% | 22,727 | -0.2% | 0.43% | -16.5% |
| Q3 2021 | $3,868,000 | +5.9% | 22,778 | -1.5% | 0.52% | +7.3% |
| Q2 2021 | $3,652,000 | +9.9% | 23,130 | -3.4% | 0.48% | +3.0% |
| Q1 2021 | $3,324,000 | -24.3% | 23,939 | -4.5% | 0.47% | -28.0% |
| Q4 2020 | $4,391,000 | – | 25,071 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |